UB Paderborn / Katalog / Suche / in CDI

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

PloS one, 2022-09, Vol.17 (9), p.e0274969-e0274969

2022

Link zum Volltext

Verfügbarkeit prüfen

Short-acting β -agonist use and its ability to predict future asthma-related outcomes

Annals of allergy, asthma, & immunology, 2012-12, Vol.109 (6), p.403-407

2012

Link zum Volltext

Verfügbarkeit prüfen

Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer

Thrombosis research, 2023-04, Vol.224, p.52-59

2023

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs

The American journal of cardiology, 2022-01, Vol.163, p.43-49

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis

Seminars in thrombosis and hemostasis, 2024-04, Vol.50 (3), p.328

2024

Link zum Volltext

Verfügbarkeit prüfen

Payer formulary tier increases of apixaban: how patients respond and potential implications

Current medical research and opinion, 2023-08, Vol.39 (8), p.1-1101

2023

Link zum Volltext

Verfügbarkeit prüfen

COPD exacerbation frequency and its association with health care resource utilization and costs

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.2609-2618

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Current medical research and opinion, 2022-11, Vol.38 (11), p.1891-1896

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Journal of the American Geriatrics Society (JAGS), 2019-08, Vol.67 (8), p.1662-1671

2019

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk

Future oncology (London, England), 2024-03, Vol.20 (9), p.521-532

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Current medical research and opinion, 2024-03, Vol.40 (3), p.545-553

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.735-744

2017

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity

Advances in therapy, 2023-03, Vol.40 (3), p.887-902

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use: A Cross-Sectional Analysis of National Survey Data

Journal of occupational and environmental medicine, 2016-06, Vol.58 (6), p.e191-e197

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

Advances in therapy, 2021-11, Vol.38 (11), p.5519-5533

2021

Link zum Volltext

Verfügbarkeit prüfen

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Therapeutic advances in gastroenterology, 2021, Vol.14, p.1756284821997352-1756284821997352

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Mayo Clinic proceedings, 2020-05, Vol.95 (5), p.929-943

2020

Link zum Volltext

Verfügbarkeit prüfen

Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

American heart journal plus, 2024-03, Vol.39, p.100369-100369, Article 100369

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure

PloS one, 2019-03, Vol.14 (3), p.e0213614-e0213614

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022-05, Vol.22 (3), p.333-343

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.115-122

2017

Link zum Volltext

Verfügbarkeit prüfen

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Current medical research and opinion, 2019-10, Vol.35 (10), p.1769-1776

2019

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

Advances in therapy, 2023-04, Vol.40 (4), p.1705-1735

2023

Link zum Volltext

Verfügbarkeit prüfen

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

Journal of medical economics, 2020-12, Vol.23 (12), p.1389-1400

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

Advances in therapy, 2021-06, Vol.38 (6), p.3166-3184

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

Short-acting β -agonist use and its ability to predict future asthma-related outcomes

Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer

Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs

Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis

Payer formulary tier increases of apixaban: how patients respond and potential implications

COPD exacerbation frequency and its association with health care resource utilization and costs

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity

Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use: A Cross-Sectional Analysis of National Survey Data

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

Suchergebnisse filtern